Cargando…

Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents

BACKGROUND: The increased incidence of type 2 diabetes mellitus among hepatitis C virus (HCV) infected patients is likely due to viral-induced insulin resistance (IR). Indeed, control of diabetes in these patients benefits of successful antiviral treatment; whether the same applies to subtler altera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gualerzi, Alessandro, Bellan, Mattia, Smirne, Carlo, Tran Minh, Margherita, Rigamonti, Cristina, Burlone, Michela Emma, Bonometti, Ramona, Bianco, Sara, Re, Azzurra, Favretto, Serena, Bellomo, Giorgio, Minisini, Rosalba, Carnevale Schianca, Gian Piero, Pirisi, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6301649/ https://www.ncbi.nlm.nih.gov/pubmed/30571711 http://dx.doi.org/10.1371/journal.pone.0209216

Ejemplares similares

Cardiac dysfunction as an early predictor of portal hypertension in chronic hepatitis C
por: Marconi, Cecilia, et al.
Publicado: (2017)

Severity of Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Mellitus: Relationship between Nongenetic Factors and PNPLA3/HSD17B13 Polymorphisms
por: Bellan, Mattia, et al.
Publicado: (2019)

Exposure to Plasma From Non-alcoholic Fatty Liver Disease Patients Affects Hepatocyte Viability, Generates Mitochondrial Dysfunction, and Modulates Pathways Involved in Fat Accumulation and Inflammation
por: Grossini, Elena, et al.
Publicado: (2021)

Liver Stiffness, Not Fat Liver Content, Predicts the Length of QTc Interval in Patients with Chronic Liver Disease
por: Bellan, Mattia, et al.
Publicado: (2019)

Periostin Circulating Levels and Genetic Variants in Patients with Non-Alcoholic Fatty Liver Disease
por: Smirne, Carlo, et al.
Publicado: (2020)

17β-Oestradiol Protects from Hepatitis C Virus Infection through Induction of Type I Interferon
por: Barbaglia, Matteo Nazzareno, et al.
Publicado: (2022)

Gas6/TAM Signaling Components as Novel Biomarkers of Liver Fibrosis
por: Smirne, Carlo, et al.
Publicado: (2019)

Sofosbuvir‐based therapies in genotype 2 hepatitis C virus cirrhosis: A real‐life experience with focus on ribavirin dose
por: Smirne, Carlo, et al.
Publicado: (2021)

Role of Gas6 and TAM Receptors in the Identification of Cardiopulmonary Involvement in Systemic Sclerosis and Scleroderma Spectrum Disorders
por: Bellan, Mattia, et al.
Publicado: (2020)

Red Cell Distribution Width and Platelet Count as Biomarkers of Pulmonary Arterial Hypertension in Patients with Connective Tissue Disorders
por: Bellan, Mattia, et al.
Publicado: (2019)

Interplay of PNPLA3 and HSD17B13 Variants in Modulating the Risk of Hepatocellular Carcinoma among Hepatitis C Patients
por: De Benedittis, Carla, et al.
Publicado: (2020)

Direct antivirals and cognitive impairment in hepatitis C: a clinical-neurophysiologic study
por: Vaghi, Gloria, et al.
Publicado: (2020)

17,β‐estradiol inhibits hepatitis C virus mainly by interference with the release phase of its life cycle
por: Magri, Andrea, et al.
Publicado: (2016)

Clinical Relevance of Liver Involvement in the Clinical Course of Systemic Sclerosis
por: Lorena, Maria, et al.
Publicado: (2022)

COVID-19 Biomarkers at the Crossroad between Patient Stratification and Targeted Therapy: The Role of Validated and Proposed Parameters
por: Rizzi, Manuela, et al.
Publicado: (2023)

Plasma Pattern of Extracellular Vesicles Isolated from Hepatitis C Virus Patients and Their Effects on Human Vascular Endothelial Cells
por: Grossini, Elena, et al.
Publicado: (2023)

Comment on “Evaluation of serum interleukin-6 levels in hepatocellular carcinoma patients: a systematic review and meta-analysis”
por: Bellan, Mattia, et al.
Publicado: (2019)

Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma
por: Manfredi, Giulia Francesca, et al.
Publicado: (2023)

The Management of Type 2 Diabetic Patients with Hypoglycemic Agents
por: Carnevale Schianca, G. P., et al.
Publicado: (2012)

Oral glucose tolerance test‐based calculation identifies different glucose intolerance phenotypes within the impaired fasting glucose range
por: Carnevale Schianca, Gian Piero, et al.
Publicado: (2014)

Identification of the Best Cut-Off Value of PIVKA-II for the Surveillance of Patients at Risk of Hepatocellular Carcinoma Development
por: Caviglia, Gian Paolo, et al.
Publicado: (2023)

Pancreatobiliary Reflux Resulting in Pancreatic Ascites and Choleperitoneum after Gallbladder Perforation
por: Rapetti, Rachele, et al.
Publicado: (2008)

Role of Osteopontin as a Potential Biomarker of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis and Other Connective Tissue Diseases (CTDs)
por: Bellan, Mattia, et al.
Publicado: (2021)

Gas6/TAM System: A Key Modulator of the Interplay between Inflammation and Fibrosis
por: Bellan, Mattia, et al.
Publicado: (2019)

SARS-CoV-2 infection risk is higher in vaccinated patients with inflammatory autoimmune diseases or liver transplantation treated with mycophenolate due to an impaired antiviral immune response: results of the extended follow up of the RIVALSA prospective cohort
por: Rizzi, Manuela, et al.
Publicado: (2023)

Rates of Symptomatic SARS-CoV-2 Infection in Patients With Autoimmune Liver Diseases in Northern Italy: A Telemedicine Study
por: Rigamonti, Cristina, et al.
Publicado: (2020)

Identification of a Functional, CRM-1-Dependent Nuclear Export Signal in Hepatitis C Virus Core Protein
por: Cerutti, Andrea, et al.
Publicado: (2011)

Increased Levels of ICOS and ICOSL Are Associated to Pulmonary Arterial Hypertension in Patients Affected by Connective Tissue Diseases
por: Bellan, Mattia, et al.
Publicado: (2022)

Levosimendan Inhibits Peroxidation in Hepatocytes by Modulating Apoptosis/Autophagy Interplay
por: Grossini, Elena, et al.
Publicado: (2015)

The Gas6/TAM System and Multiple Sclerosis
por: Bellan, Mattia, et al.
Publicado: (2016)

Candidate Biomarkers of Liver Fibrosis: A Concise, Pathophysiology-oriented Review
por: Bellan, Mattia, et al.
Publicado: (2018)

Sulfonylureas and their use in clinical practice
por: Sola, Daniele, et al.
Publicado: (2015)

Ongoing Mycophenolate Treatment Impairs Anti-SARS-CoV-2 Vaccination Response in Patients Affected by Chronic Inflammatory Autoimmune Diseases or Liver Transplantation Recipients: Results of the RIVALSA Prospective Cohort
por: Zecca, Erika, et al.
Publicado: (2022)

Prognostic Markers in Hospitalized COVID-19 Patients: The Role of IP-10 and C-Reactive Protein
por: Rizzi, Manuela, et al.
Publicado: (2022)

Pathophysiological Role and Therapeutic Implications of Vitamin D in Autoimmunity: Focus on Chronic Autoimmune Diseases
por: Bellan, Mattia, et al.
Publicado: (2020)

Altered glucose metabolism rather than naive type 2 diabetes mellitus (T2DM) is related to vitamin D status in severe obesity
por: Bellan, Mattia, et al.
Publicado: (2014)

Decreased Gas6 and sAxl Plasma Levels Are Associated with Hair Loss in COVID-19 Survivors
por: Apostolo, Daria, et al.
Publicado: (2023)

Baseline Plasma Gas6 Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients
por: Tonello, Stelvio, et al.
Publicado: (2022)

Efficacy and Safety of Sofosbuvir and Ribavirin in an Italian Cohort of HCV Genotype 2 Elderly Cirrhotic Patients
por: Smirne, Carlo, et al.
Publicado: (2022)

Diabetes and acute respiratory failure. Is the lung finally safe?
por: Gavelli, Francesco, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_85a9uqbsllch88ssk02q5kvmsc